Abstract
Autonomic neuropathy (AN) patients frequently experience multi-systemic symptoms, ranging from cardiovascular, urinary, secretory, and gastrointestinal (GI). Further, there is marked heterogeneity among patients, often limiting the yield of conventional diagnostic evaluations. The aim of this study was to describe our single-institution experience with wireless motility capsule (WMC) testing to quantitatively evaluate segmental dysfunction in AN patients with GI symptoms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
